MYSTERIOUS: Bionano genomics inc - What They Never Told You

2 Biotech Stocks You Should Buy While You Can, 1 That Investors Are Avoiding

The biotech industry is well-positioned for solid growth, thanks to the rising need for high-quality healthcare and the government's push to increase domestic biotech production and research. To that end, buying fundamentally strong biotech stocks Gilead Sciences (GILD) and Jazz Pharmaceuticals (JAZZ) could be wise. However, it could be prudent…

StockNews.com · Aug 8, 2023

Should You Watch Bionano Genomics (BNGO) this Week?

While Bionano Genomics (BNGO) is witnessing steady revenue growth, its bottom line remains in the red. Let’s dive deeper into its key financial metrics to analyze if BNGO is worth adding to your watchlists.

StockNews.com · Jun 27, 2023

Is Bionano Genomics (BNGO) a Buy or Sell this Week?

Genomic testing devices manufacturer Bionano Genomics (BNGO) is witnessing steady revenue growth. However, unfortunately, it did not translate into a bottom-line improvement. Moreover, as BNGO faces the possibility of delisting, is it worth buying now? Keep reading.

StockNews.com · Jun 16, 2023

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com · Nov 23, 2022

1 Biotech Stock You Shouldn't Follow Wall Street's Bullishness On

Wall Street analysts expect Biotech stock Bionano Genomics (BNGO) to grow more than 160% in the near term. However, the stock’s fundamentals appear bleak, and the stock has lost more than 20% in 2022. Therefore, investors might avoid following Wall Street’s bullishness on this stock. Let’s find out….

StockNews.com · Nov 7, 2022

3 Stocks to Short in May, Despite the Recent Market Sell-Off

The major market indexes have witnessed a massive sell-off recently. And this has significantly benefited short-sellers. Given the possibility of further market corrections, Lightning eMotors (ZEV), Bionano Genomics (BNGO), and QuantumScape (QS) could be ideal candidates for shorting this month, as they still look overvalued at their current price levels.

StockNews.com · May 16, 2022